230 related articles for article (PubMed ID: 22404718)
1. C4.4A is associated with tumor budding and epithelial-mesenchymal transition of colorectal cancer.
Oshiro R; Yamamoto H; Takahashi H; Ohtsuka M; Wu X; Nishimura J; Takemasa I; Mizushima T; Ikeda M; Sekimoto M; Matsuura N; Doki Y; Mori M
Cancer Sci; 2012 Jun; 103(6):1155-64. PubMed ID: 22404718
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
4. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
[TBL] [Abstract][Full Text] [Related]
5. Concurrent expression of C4.4A and Tenascin-C in tumor cells relates to poor prognosis of esophageal squamous cell carcinoma.
Ohtsuka M; Yamamoto H; Oshiro R; Takahashi H; Masuzawa T; Uemura M; Haraguchi N; Nishimura J; Hata T; Yamasaki M; Takemasa I; Miyata H; Mizushima T; Takiguchi S; Doki Y; Mori M
Int J Oncol; 2013 Aug; 43(2):439-46. PubMed ID: 23708783
[TBL] [Abstract][Full Text] [Related]
6. Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients.
Lee SJ; Choi SY; Kim WJ; Ji M; Lee TG; Son BR; Yoon SM; Sung R; Lee EJ; Youn SJ; Park SM
Diagn Pathol; 2013 Jun; 8():99. PubMed ID: 23783026
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin.
Xiao S; Liu L; Lu X; Long J; Zhou X; Fang M
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1465-74. PubMed ID: 25716692
[TBL] [Abstract][Full Text] [Related]
8. High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cells.
Fujikawa H; Tanaka K; Toiyama Y; Saigusa S; Inoue Y; Uchida K; Kusunoki M
J Gastroenterol; 2012 Jul; 47(7):775-84. PubMed ID: 22361863
[TBL] [Abstract][Full Text] [Related]
9. Tumor budding at the invasive front of colorectal cancer may not be associated with the epithelial-mesenchymal transition.
Yamada N; Sugai T; Eizuka M; Tsuchida K; Sugimoto R; Mue Y; Suzuki M; Osakabe M; Uesugi N; Ishida K; Otsuka K; Matsumoto T
Hum Pathol; 2017 Feb; 60():151-159. PubMed ID: 27836787
[TBL] [Abstract][Full Text] [Related]
10. Expression of C4.4A at the invasive front is a novel prognostic marker for disease recurrence of colorectal cancer.
Konishi K; Yamamoto H; Mimori K; Takemasa I; Mizushima T; Ikeda M; Sekimoto M; Matsuura N; Takao T; Doki Y; Mori M
Cancer Sci; 2010 Oct; 101(10):2269-77. PubMed ID: 20825414
[TBL] [Abstract][Full Text] [Related]
11. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis.
Yuan Z; Yu X; Ni B; Chen D; Yang Z; Huang J; Wang J; Chen D; Wang L
Int J Oncol; 2016 Jun; 48(6):2675-85. PubMed ID: 27035092
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma.
Hansen LV; Laerum OD; Illemann M; Nielsen BS; Ploug M
Int J Cancer; 2008 Feb; 122(4):734-41. PubMed ID: 17849475
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
15. BMAL1 Knockdown Leans Epithelial-Mesenchymal Balance toward Epithelial Properties and Decreases the Chemoresistance of Colon Carcinoma Cells.
Zhang Y; Devocelle A; Desterke C; de Souza LEB; Hadadi É; Acloque H; Foudi A; Xiang Y; Ballesta A; Chang Y; Giron-Michel J
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065633
[TBL] [Abstract][Full Text] [Related]
16. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition.
Cheng XS; Li YF; Tan J; Sun B; Xiao YC; Fang XB; Zhang XF; Li Q; Dong JH; Li M; Qian HH; Yin ZF; Yang ZB
Cancer Lett; 2014 Jun; 348(1-2):77-87. PubMed ID: 24657657
[TBL] [Abstract][Full Text] [Related]
17. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
19. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
[TBL] [Abstract][Full Text] [Related]
20. Bidirectional KCNQ1:β-catenin interaction drives colorectal cancer cell differentiation.
Rapetti-Mauss R; Bustos V; Thomas W; McBryan J; Harvey H; Lajczak N; Madden SF; Pellissier B; Borgese F; Soriani O; Harvey BJ
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):4159-4164. PubMed ID: 28373572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
